RHYTHM PHARMACEUTICALS, INC. — Director's Dealing 2020

Oct 6, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RHYTHM PHARMACEUTICALS, INC. (RYTM)
CIK: 0001649904
Period of Report: 2020-10-05

Reporting Person: Mazabraud Yann (EVP, Head of International)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-10-05	Stock Option (Right to Buy)	$22.28	A	100000	Acquired	2030-10-04	Common Stock (100000)	Direct

Footnotes

F1: The stock options were granted on October 5, 2020. 25% of the shares subject to the option will vest and become exercisable on October 5, 2021 and the remaining 75% of the shares subject to the option shall vest and become exercisable in 12 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer thereafter.